Treatment of ANCA-associated vasculitis

Ulf Schönermarck, Wolfgang L. Gross, Kirsten De Groot*

*Korrespondierende/r Autor/-in für diese Arbeit
43 Zitate (Scopus)

Abstract

Antineutrophil cytoplasmic autoantibody (ANCA)-associated diseases are small-vessel vasculitides, encompassing granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. Once considered life-threatening diseases, the introduction of stage-adapted immunosuppressive therapy and medications with decreased toxicity has improved patients' survival. Treatment is biphasic, consisting of induction of remission (3-6 months) for rapid control of disease activity and maintenance of remission (at least 18 months) to prevent disease relapse using therapeutic alternatives that have reduced toxicity. This Review summarizes current treatment strategies for these diseases, with a special focus on long-term follow-up data from key randomized controlled trials and new developments in remission induction and maintenance therapy. Current treatment strategies have substantial short-term and long-term adverse effects, and relapses are frequent; thus, less-toxic and more-effective approaches are needed. Moreover, the optimal intensity and duration of maintenance therapy remains under debate. Clinical trials have traditionally considered ANCA-associated vasculitides as a single disease entity. However, future studies must stratify participants according to their specific disease, clinical features (different types of organ manifestation, PR3-ANCA or MPO-ANCA positivity) and disease severity.

OriginalspracheEnglisch
ZeitschriftNature Reviews Nephrology
Jahrgang10
Ausgabenummer1
Seiten (von - bis)25-36
Seitenumfang12
ISSN1759-5061
DOIs
PublikationsstatusVeröffentlicht - 01.2014

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Treatment of ANCA-associated vasculitis“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren